Institutional Repository (UniKL IR)
Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/11730| Title: | Drug Eluting Stent (DES) Therapy in Coronary Artery Disease. |
| Authors: | Mishra., N.K. ; FPHS UniKL RCMP. Dash., G.K. ; FPHS UniKL RCMP. Mishra., G. ; FPHS UniKL RCMP. Padhiary., T.K. ; FPHS UniKL RCMP. Sravani., B.S. ; FPHS UniKL RCMP. Kumari., G. Santoshi ; FPHS UniKL RCMP. Senapathy., Bharath ; FPHS UniKL RCMP. |
| Keywords: | CAD Drug-eluting stents Metallic stent |
| Issue Date: | 2015 |
| Publisher: | Pharma Science Monitor An International Journal of Pharmaceutical Sciences. |
| Citation: | Mishra.,N.K., Dash.,G.K, Mishra.,G., Padhiary,T.K., Sravani,B.S., Kumari., G.S. & Senapathy, B. (2015). Drug Eluting Stent (DES) Therapy in Coronary Artery Disease. Pharma Science Monitor An International Journal of Pharmaceutical Sciences. 6(1), pp 208-216 |
| Abstract: | The cardiovascular dis-orders are increasing day by day. Coronary artery disease (CAD) is currently a leading cause of death worldwide. Drug-eluting stents (DESs) have been dominant for the treatment of CAD in the interventional cardiology world owing to their efficacy in significantly reducing restenosis as compare to metallic stents. However, late stage stent thrombosis has become a major concern. Stent platform, drug delivery vehicle and types of drugs are three parts of DES and each part affects the performance of the DES. This review gives real answer about safety control of restenosis and thrombosis in CAD by using drug eluting stent. |
| URI: | http://ir.unikl.edu.my/jspui/handle/123456789/11730 |
| Appears in Collections: | Conference Paper |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 10.docx | 119.15 kB | Microsoft Word XML | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.